We are here to modernize
reproductive care
Gynecologic health made easy
Non-surgical diagnostics and treatment
Delivers the world’s first
non-surgical fertility/infertility diagnostics and treatment that can be done by any Ob/Gyn physician.
In-office process
Champions the move to local doctor’s offices without the need or expense of a specialized clinic.
More efficient
Eliminates the need for surgery and associated specialists/costs: surgical theater, anesthesia, etc.
Safe experience
Provides women with safe, easy, and effective uterine care and a much-enhanced treatment experience.
Low-cost
Creates a game-changing
low-cost alternative to
traditional IVF.
Innovation
Opens and expands multiple, global universally-unserved fertility and infertility markets.
Our mission
Deliver the world’s first non-surgical platform for fertility (egg/embryo retrieval) and uterine diagnostics and treatment.
We see a world where everyone can access safe, effective, and affordable fertility and gynecologic care.
Our technology
Our unique technology is IP-protected with 11 US patents, 1 foreign–issued patent, and 12 patents pending, providing a comprehensive, easy-to-use in-office solution for the majority of intrauterine procedures.
We have created the world’s first non-surgical fertility Platform and treatments that will transform and expand fertility care by making treatments available through the network of tens of thousands of Ob/Gyn physicians in the US and around the world.
Our trajectory
We are currently pre-market and post-pivotal study. Our Platform is fully validated for its intended uses, and we are currently undergoing regulatory approval and development of our manufacturing capability.
We anticipate FDA regulatory for gynecologic care in 2023, approval for gynecologic and fertility care in Europe in early 2024, and full approval in the USA for fertility care in late 2024.
